Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $82.56M (100.0% shares, 0.0% debt)

Holdings (17)

— REATA PHARMACEUTICALS INC-A 13.0%

Value $10.76M Shares 105,558 Est. Cost $101.96 Unrealized —

— VERONA PHARMA PLC - ADR 12.5%

Value $10.31M Shares 487,631 Est. Cost $20.08 Unrealized —

XENE XENON PHARMACEUTICALS INC 12.4%

Value $10.28M Shares 266,961 Est. Cost $36.94 Unrealized +7.6%

CYTK CYTOKINETICS INC 8.8%

Value $7.287M Shares 223,382 Est. Cost $40.80 Unrealized -9.3%

GERN GERON CORP 8.3%

Value $6.815M Shares 2,123,162 Est. Cost $2.85 Unrealized 0.0%

— MERUS NV 6.4%

Value $5.245M Shares 199,221 Est. Cost $18.40 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 5.8%

Value $4.8M Shares 201,752 Est. Cost $25.65 Unrealized 0.0%

MLTX MOONLAKE IMMUNOTHERAPEUTICS 5.6%

Value $4.662M Shares 91,413 Est. Cost $18.86 Unrealized +42.6%

— MARINUS PHARMACEUTICALS INC 5.1%

Value $4.24M Shares 390,418 Est. Cost $10.86 Unrealized —

BDTX BLACK DIAMOND THERAPEUTICS I 4.9%

Value $4.04M Shares 800,000 Est. Cost $2.04 Unrealized 0.0%

— PRAXIS PRECISION MEDICINES I 4.5%

Value $3.68M Shares 3,200,000 Est. Cost $1.15 Unrealized —

— JASPER THERAPEUTICS INC 4.2%

Value $3.449M Shares 2,517,232 Est. Cost $1.81 Unrealized —

CMPX COMPASS THERAPEUTICS INC 3.5%

Value $2.909M Shares 914,630 Est. Cost $3.14 Unrealized 0.0%

— MEDAVAIL HOLDINGS INC 1.8%

Value $1.445M Shares 5,894,897 Est. Cost $8.23 Unrealized —

— MDXHEALTH SA-ADR 1.4%

Value $1.192M Shares 349,552 Est. Cost $3.24 Unrealized —

CNTX CONTEXT THERAPEUTICS INC 1.3%

Value $1.045M Shares 653,396 Est. Cost $0.85 Unrealized 0.0%

RPID RAPID MICRO BIOSYSTEMS INC-A 0.5%

Value $403K Shares 403,284 Est. Cost $15.69 Unrealized -93.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	REATA PHARMACEUTICALS INC-A	105,558	$10.76M	13.0%	$101.96	—	CL A	75615P103
—	VERONA PHARMA PLC - ADR	487,631	$10.31M	12.5%	$20.08	—	SPONSORED ADS	925050106
XENE	XENON PHARMACEUTICALS INC	266,961	$10.28M	12.4%	$36.94	+7.6%	COM	98420N105
CYTK	CYTOKINETICS INC	223,382	$7.287M	8.8%	$40.80	-9.3%	COM NEW	23282W605
GERN	GERON CORP	2,123,162	$6.815M	8.3%	$2.85	0.0%	COM	374163103
—	MERUS NV	199,221	$5.245M	6.4%	$18.40	—	COM	N5749R100
VRDN	VIRIDIAN THERAPEUTICS INC	201,752	$4.8M	5.8%	$25.65	0.0%	COM	92790C104
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	91,413	$4.662M	5.6%	$18.86	+42.6%	CLASS A ORD	61559X104
—	MARINUS PHARMACEUTICALS INC	390,418	$4.24M	5.1%	$10.86	—	COM NEW	56854Q200
BDTX	BLACK DIAMOND THERAPEUTICS I	800,000	$4.04M	4.9%	$2.04	0.0%	COM	09203E105
—	PRAXIS PRECISION MEDICINES I	3,200,000	$3.68M	4.5%	$1.15	—	COM	74006W108
—	JASPER THERAPEUTICS INC	2,517,232	$3.449M	4.2%	$1.81	—	COM	471871103
CMPX	COMPASS THERAPEUTICS INC	914,630	$2.909M	3.5%	$3.14	0.0%	COM	20454B104
—	MEDAVAIL HOLDINGS INC	5,894,897	$1.445M	1.8%	$8.23	—	COM	58406B103
—	MDXHEALTH SA-ADR	349,552	$1.192M	1.4%	$3.24	—	SPONSORED ADS	58286E102
CNTX	CONTEXT THERAPEUTICS INC	653,396	$1.045M	1.3%	$0.85	0.0%	COM	21077P108
RPID	RAPID MICRO BIOSYSTEMS INC-A	403,284	$403K	0.5%	$15.69	-93.6%	CLASS A COM	75340L104